Clinical Trials and Regulatory Affairs

Clinical trials and regulatory affairs are critical components in the development and approval of vaccines, ensuring that they are both safe and effective for public use. Clinical trials follow a rigorous, multi-phase process to evaluate a vaccine's efficacy, safety, and optimal dosage, involving diverse participant groups to assess its impact across different populations. Each phase of the trial provides valuable data, from initial safety assessments in small groups to broader efficacy studies in larger populations. 

 

    Related Conference of Clinical Trials and Regulatory Affairs

    October 31-01, 2024

    36th International Conference on Vaccines and Immunization

    Amsterdam, Netherlands
    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France
    December 05-06, 2024

    36th Annual Congress on Vaccine and Clinical Trials

    Vancouver, Canada
    February 27-28, 2025

    8th International Conference on Vaccines and Immunology

    Paris, France
    April 28-29, 2025

    2nd Global Summit on Vaccines & Emerging Diseases

    Bali, Indonesia

    Clinical Trials and Regulatory Affairs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in